Completed
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
NCT05228470
- Conditions
- BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China